At a glance
ClinicalIndex Comparison RecordN/ACompleted· 108 enrolled
Drug / intervention
Ketamine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Single Dose Ketamine and Magnesium on Postoperative Pain in Patients Undergoing Bariatric Surgery
In Brief
A clinical study evaluating Ketamine, Ketamine plus magnesium, and 1 other intervention for Obesity. Completed, enrolled 108 participants across 1 site.
Detailed Summary
Opioid sparing analgesia is extremely important in the post-operative obese population. With more and more obese patients entering the operating room a multi-modal approach to analgesia is crucial. Finding effective alternatives to opioid therapy is the rationale of this proposal. Literature involving ketamine and magnesium in bariatric surgical patients is very sparse.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 2015
Enrollment StartNov 2015
Primary CompletionMar 2019
TodayJul 2026
First PostedJan 8, 2015
Enrollment StartNov 1, 2015
Primary CompletionMar 13, 2019
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 11.5 years ago
Interventions
Ketaminedrug
Ketamine infusion plus placebo infusion of normal saline
Ketamine plus magnesiumdrug
Ketamine plus magnesium infusion
Placeboother
2 placebo infusions